Targeting SPOP with small molecules provides a novel strategy for kidney cancer therapy

• 作 者: Tong Zheng Cai-Guang Yang
• 机 构: LaboratoryofChemicalBiology,UniversityofChineseAcademyofSciences
• 出 处: Science China(Life Sciences)
• 发表日期: 2017年1期
• 关键词: Targeting accounting metastatic eventually manipulation mortality chemotherapy c

<正>Renal cell carcinoma(RCC),accounting for 4%of all cancers,is the second most common cancer in urology.The most common form of RCC is clear cell RCC(ccRCC),with a ratio over 70%.Early-phase kidney diseases usually show rare symptoms in clinic;unfo